MY152276A - Synthesis of morphine-6-glucuronide or one of the derivatives thereof - Google Patents

Synthesis of morphine-6-glucuronide or one of the derivatives thereof

Info

Publication number
MY152276A
MY152276A MYPI20112601A MY152276A MY 152276 A MY152276 A MY 152276A MY PI20112601 A MYPI20112601 A MY PI20112601A MY 152276 A MY152276 A MY 152276A
Authority
MY
Malaysia
Prior art keywords
group
glucuronide
derivatives
morphine
reacting
Prior art date
Application number
Other languages
English (en)
Inventor
Alain Dlubala
Isabelle Ripoche
Claire Trecant
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MY152276A publication Critical patent/MY152276A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MYPI20112601 2008-12-10 2009-12-08 Synthesis of morphine-6-glucuronide or one of the derivatives thereof MY152276A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806948A FR2939436B1 (fr) 2008-12-10 2008-12-10 Synthese de morphine-6-glucuronide ou de l'un de ses derives

Publications (1)

Publication Number Publication Date
MY152276A true MY152276A (en) 2014-09-15

Family

ID=40996840

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20112601 MY152276A (en) 2008-12-10 2009-12-08 Synthesis of morphine-6-glucuronide or one of the derivatives thereof

Country Status (30)

Country Link
US (1) US8258298B2 (https=)
EP (1) EP2376496B1 (https=)
JP (1) JP5619768B2 (https=)
KR (1) KR20110091534A (https=)
CN (1) CN102307876B (https=)
AR (1) AR074513A1 (https=)
AU (1) AU2009326906B2 (https=)
BR (1) BRPI0923238A2 (https=)
CA (1) CA2746428A1 (https=)
CL (1) CL2011001398A1 (https=)
CO (1) CO6390060A2 (https=)
CR (1) CR20110307A (https=)
EA (1) EA201170790A1 (https=)
EC (1) ECSP11011100A (https=)
ES (1) ES2470666T3 (https=)
FR (1) FR2939436B1 (https=)
HN (1) HN2011001597A (https=)
IL (1) IL213379A0 (https=)
MA (1) MA32950B1 (https=)
MX (1) MX337925B (https=)
MY (1) MY152276A (https=)
NI (1) NI201100116A (https=)
NZ (1) NZ593342A (https=)
PE (1) PE20110836A1 (https=)
SG (1) SG172069A1 (https=)
TN (1) TN2011000243A1 (https=)
TW (1) TW201033218A (https=)
UA (1) UA103643C2 (https=)
WO (1) WO2010067007A2 (https=)
ZA (1) ZA201104657B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10807995B2 (en) 2018-07-13 2020-10-20 Alkermes Pharma Ireland Limited Thienothiophene compounds for long-acting injectable compositions and related methods
US10799496B2 (en) 2018-07-13 2020-10-13 Alkermes Pharma Ireland Limited Naphthylenyl compounds for long-acting injectable compositions and related methods
US10975099B2 (en) 2018-11-05 2021-04-13 Alkermes Pharma Ireland Limited Thiophene compounds for long-acting injectable compositions and related methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) * 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
DE69815336T2 (de) 1997-04-14 2004-05-06 Ufc Ltd. Morphin-derivate
PL194362B1 (pl) * 1998-06-06 2007-05-31 Cenes Ltd Sposób syntezy beta-anomeru morfino-6-glukuronidui zastosowanie związków
GB9914382D0 (en) * 1999-06-21 1999-08-18 Ufc Limited New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
KR20040014544A (ko) * 2001-06-05 2004-02-14 컨트롤 딜리버리 시스템즈 인코포레이티드 서방 진통제 화합물
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
KR20050008658A (ko) * 2002-03-19 2005-01-21 마이클 홀릭 아포모르핀의 글리코시드 및 오르토에스테르 글리코시드유도체들, 유사체들 및 그것의 용도
FR2864082B1 (fr) 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur

Also Published As

Publication number Publication date
SG172069A1 (en) 2011-07-28
ECSP11011100A (es) 2011-07-29
WO2010067007A3 (fr) 2011-07-07
HN2011001597A (es) 2013-09-09
ES2470666T3 (es) 2014-06-24
CO6390060A2 (es) 2012-02-29
UA103643C2 (ru) 2013-11-11
PE20110836A1 (es) 2011-11-25
TW201033218A (en) 2010-09-16
CN102307876B (zh) 2014-12-10
FR2939436A1 (fr) 2010-06-11
JP5619768B2 (ja) 2014-11-05
EA201170790A1 (ru) 2011-12-30
NZ593342A (en) 2013-07-26
KR20110091534A (ko) 2011-08-11
CR20110307A (es) 2011-09-21
EP2376496A2 (fr) 2011-10-19
AR074513A1 (es) 2011-01-19
AU2009326906A1 (en) 2011-06-30
FR2939436B1 (fr) 2010-12-17
AU2009326906B2 (en) 2016-05-26
CA2746428A1 (fr) 2010-06-17
TN2011000243A1 (fr) 2012-12-17
CN102307876A (zh) 2012-01-04
JP2012511551A (ja) 2012-05-24
ZA201104657B (en) 2012-09-26
HK1163096A1 (en) 2012-09-07
WO2010067007A2 (fr) 2010-06-17
BRPI0923238A2 (pt) 2016-01-26
US20110275820A1 (en) 2011-11-10
CL2011001398A1 (es) 2011-10-28
MA32950B1 (fr) 2012-01-02
IL213379A0 (en) 2011-07-31
EP2376496B1 (fr) 2014-03-12
MX2011006264A (es) 2011-11-04
NI201100116A (es) 2011-12-14
MX337925B (es) 2016-03-28
US8258298B2 (en) 2012-09-04

Similar Documents

Publication Publication Date Title
WO2008022777A3 (de) Verfahren zum herstellen von 3-dihalomethyl-pyrazol-4-carbonsäurederivaten
WO2010111280A8 (en) Functional polyisobutylene based macromonomers and methods for making and using the same
WO2007092641A3 (en) Method for substituted 1h-imidazo[4,5-c]pyridines
WO2010008847A3 (en) Pi3k/m tor inhibitors
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
EP2105451A3 (en) Nitrile group-containing polymer and method of synthesizing the same, composition containing nitrile group-containing polymer, and laminate
WO2009122436A3 (en) An improved process for the preparation of morphinane analogues
WO2009083532A3 (en) Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof
UA101835C2 (uk) Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
MY152276A (en) Synthesis of morphine-6-glucuronide or one of the derivatives thereof
WO2009135598A8 (en) Process for preparing substituted biphenylanilides
WO2008110908A8 (en) Method for preparing hydroxytyrosol derivatives and of hydroxytyrosol
WO2006133397A3 (en) Process for the synthesis of triazoles
WO2008092583A8 (de) Verfahren zum herstellen von dihaloacetessigsäurealkylestern
WO2007107345A3 (en) PROCESS FOR PREPARING l-HALO-2,7-NAPHTHYRIDINYL DERIVATIVES
WO2010086667A3 (en) Compositions comprising sugar ester of mycolic acid derivatives and process the preparation thereof
WO2007143014A3 (en) Methods for preparing glutamic acid derivatives and intermediates thereof
WO2007085651A8 (en) Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds
WO2007083243A3 (en) An improved process for the preparation of risedronate sodium hemi-pentahydrate
TW200740763A (en) A method for preparing 5-hydroxy-1-alkyl pyrazole derivatives
WO2009030725A3 (en) Azaindoles as inhibitors of soluble adenylate cyclase
WO2010022033A3 (en) Therapeutic substituted pyrroles
WO2011023280A8 (en) Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids